Biological Information

Background Information:

Opiates exert their effects in the central and peripheral nervous systems through interaction with m, k and d, three major types of opioid receptors, which are structural homologues and belong to the G protein-coupled receptor (GPCR) family. G-protein cascades activated by these three receptors can reduce adenylyl cyclase activity, alter inositol trisphosphate turnover, activate G-protein-linked, inward potassium channels, and close calcium channels. These receptors mediate the actions of opiate drugs and endogenous opioid neuropeptides in producing euphoria, modulating pain perception, and altering other important functions in the central and peripheral nervous systems.

Family:

GPCR

Sub Family:

Opioid

Class:

Class A

Protein Name:

mu (MOP)

Uniprot Number:

P35372

Protein Aliases:

MOR-1|Mu opiate receptor|Mu opioid receptor|MOP|hMOP

Gene Name:

OPRM1

Gene ID:

4988

Gene Aliases:

MOR1

Accession Number:

NM_000914

Organism:

Human

Construct Details:

Recombinant

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Binding

Detection Method:

Radiometric

Measured Response:

Scintillation

Testing Information

Ligand:

[3H]DAMGO

Ligand Kd (nM):

0.35

Ligand Concentration:

0.5 nM

Non Specific:

10 µM Naloxone

Incubation:

120 min at RT

Control Inhibitor:

DAMGO

Test Concentration / Dose:

Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.

Test Sample Requirements:

Minimum for 1) Screen: 60 µl of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM final testing. 2) Dose Response: 90 µl of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.

Minimum Order Quantity:

2

Turnaround Time

Standard:

10 Business Days

Reference Compound Data

PubChem ID

104787

Name

DPDPE

Measurement

273nM - IC50

PubChem ID

5284596

Name

Naloxone

Measurement

0.43nM - IC50

PubChem ID

5462471

Name

DAMGO

Measurement

0.537nM - IC50

PubChem ID

91826457

Name

U 50488 hydrochloride

Measurement

280nM - IC50

Clinical Relevance

Therapeutic Area:

CNS/Addiction/Pain

Adverse / Beneficial Action:

Opioid receptor agonists may be analgesic, reduce gastrointestinal transit, adversely affect respiration and become addictive.

Additional Information

Brand:

LeadHunter

Testing Location:

France - Celle L'Evescault

RELATED SOLUTIONS

Item: 1392
Item: P1
Item: P22-p
Item: P270
Item: P293
Item: P3
Item: P342
Item: P411
Item: P447
Item: P456